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The present study investigates the role of nitric oxide and the involvement of nitric oxide synthase II isoform on the invasion
of human colorectal adenocarcinoma cell lines HRT-18 and HT-29. HRT-18 cells, which constitutively express nitric oxide
synthase II mRNA were three-fold more invasive in a Matrigel
1 invasion assay than nitric oxide synthase II mRNA negative
HT-29 cells. Treatment of HT-29 cells with the nitric oxide donor Deta NONOate (50 nM) as well as induction of nitric
oxide synthase II mRNA and production of endogenous nitric oxide by inﬂammatory cytokines (IFN-g and IL-1a) increased
the invasiveness of HT-29 cells by approximately 40% and 75%, respectively. In HT-29 cells nitric oxide synthase II mRNA was
also induced in co-culture with human monocytes. The invasiveness of HRT-18 cells and stimulated HT-29 cells was partly
inhibited by the nitric oxide synthase II inhibitor 1400 W. These results show that nitric oxide increases the invasion of human
colorectal adenocarcinoma cell lines HRT-18 and HT-29, and the involvement of nitric oxide synthase II isoform in tumour cell
invasion. Therefore, the production of nitric oxide and secretion of pro-inﬂammatory cytokines by tumour-associated
macrophages, which in turn induce nitric oxide synthase II isoform in tumour cells, promotes tumour cell invasiveness.
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There is no doubt that tumour-associated macrophages (TAM) are
an important component of the tumour stroma. They affect the
behaviour of tumour cells by a variety of mediators. One of these
mediators is nitric oxide (NO). NO is produced by three isoforms
of the nitric oxide synthase (NOS I-III) using L-arginine as
substrate. In macrophages NOS II is generally inducible by inﬂam-
matory stimuli and mediates a high-output long-lasting release of
NO. Because NO is the source of reactive nitrogen intermediates
(RNI), the NOS II induction is one part of macrophage cytotoxi-
city against tumour cells. On the other hand, NO favours
neoangiogenesis, if NO concentrations do not reach a cytotoxic
level (Wink et al, 1998). In human malignant tumours high NO
concentrations have been measured in vivo. Although the main
source of NO probably are tumour-associated macrophages, there
are some reports that the synthesis of NO is inducible by cytokines
in some human carcinoma cell lines like DLD-1, HT-29, A-172 and
NIH:OVCAR-3 (Thomsen and Miles, 1998). The biological signiﬁ-
cance of NO in malignant tumours is not clear, but a recent study
suggest that a high expression of NOS II and NOS III is associated
with aggressive behaviour of colorectal adenocarcinomas (Yagihashi
et al, 2000). The aim of the present study was to investigate if NO
is able to modulate tumour cell invasiveness of human colorectal
adenocarcinoma cell lines (HRT-18 and HT-29), and whether
NO can be induced by cytokines produced by stromal macro-
phages.
MATERIALS AND METHODS
Monocyte isolation
Monocytes were isolated from buffy coats with Ficoll-Paque (Phar-
macia, Freiburg, Germany) followed by hypotonic density gradient
centrifugation in Percoll (Pharmacia) as previously described in
detail (Feige et al, 1982). Prior co-culture experiments pooled
monocytes were cultivated for 24 h in hydrophobic Teﬂon bags
(Heraeus, Osterode, Germany) in RPMI-1640 medium (Biochrom,
Berlin, Germany) with 10% human AB serum (PAA, Co ¨lbe,
Germany) and 1% glutamine (PAA) at a cell density of 2610
6
per ml. About 80% of these cells were monocytes, as shown by
non-speciﬁc esterase activity (Sigma, Deisenhofen, Germany).
Tumour cells
The human colorectal adenocarcinoma cell lines HRT-18 and HT-
29 were obtained from the Cell Lines Service (Heidelberg,
Germany) and maintained in McCOY’s 5A medium (Gibco, Eggen-
stein, Germany) supplemented with 10% foetal calf serum (PAA).
Co-culture of HT-29 cells and monocytes
HT-29 cells and monocytes co-culture was performed in 7.5 cm
transwell plates with cell-impermeable membranes (pore size
0.4 mm, Corning Costar) in McCOY’s 5A medium. Monocytes
were added onto the transwell membrane above a subconﬂuent
HT-29 monolayer in a monocyte:tumour cell ratio of 2:1. For
RT–PCR total RNA was separately isolated from HT-29 cells
and monocytes after 4, 8, 24 and 48 h of co-culture and monocul-
ture. For nitrite determination supernatants were harvested in
parallel, centrifuged and frozen at 7208C.
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Subconﬂuent monolayers were cultured in serumfree McCOY’s 5A
medium for 24 h. Thereafter, different concentrations of human
rIFN-g (Sigma) and human rIL-1a (Tebu, Frankfurt, Germany)
were added with fresh medium. After 72 h total RNA was isolated,
and supernatants were collected.
Reverse transcription – polymerase chain reaction (RT–
PCR); Reverse transcription – multiplex polymerase chain
reaction (RT–MPCR)
For both total RNA was isolated by the phenol/isothiocyanate
method using Trizol-reagent (Gibco). RT–PCR: after cDNA synth-
esis efﬁciency was controlled by PCR for glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH). The primers used for ampli-
ﬁcation of GAPDH and NOS II are shown in Table 1. RT–
MPCR: after cDNA synthesis, CytoXpress MPCR Kit For Human
NO Metabolism Genes was used following the manufacturer’s
recommendations (Biosource International, Camarillo, USA) to
detect mRNA of GAPDH, TNF-a, IL-1b, NOS I-III. Ampliﬁcation
products were separated on 2 or 3% agarose gels and stained with
ethidium bromide.
Measurement of nitrate and nitrite
Nitrate and nitrite as stable products of NO were measured with the
Cayman Chemical Nitrate/ Nitrite Assay Kit (Alexis, Gru ¨nberg,
Germany) in cell culture supernatants. According to the manufac-
turer’s instruction nitrate was ﬁrst converted to nitrite and than the
GriessReagentswereadded,whichreacttoapurplecompound.Absor-
bance, photometrically measured, determines nitrite concentration.
Invasion assay
Invasion of tumour cells was determined using modiﬁed Boyden
Chamber technology. Transwells with polycarbonate membranes
(8 mm pore size) in six-well tissue culture plates (Corning Costar,
Bodenheim, Germany) were precoated with Matrigel
1 Basement
Membrane Matrix (Becton Dickinson, Heidelberg, Germany)
diluted in serum free McCOY’s 5A (1 mg ml
71; 675 ml per trans-
well) and were incubated for 2 h at 378C. Thereafter, transwells
were rinsed with serum free medium and tumour cells were seeded
at a concentration of 1.3610
5 per ml (1.5 ml) into the transwell.
NO donor or NOS inhibitor was added to the upper and to the
lower compartment. After 72 h, cultures were incubated with
0.5 mg ml
71 3-(4,5-dimethylthiazole-2-yl)-2.5-diphenyltetrazolium
bromide (MTT) for 4 h, as described (Imamura et al, 1994). Inva-
sive cells attached to the bottom of the polycarbonate membrane
were scrapped off and rinsed into the lower tissue culture well with
DMSO. After that, noninvasive cells in the transwell were disolved
with DMSO. Formazan solutions were transfered in a 96-well
microplate and absorbance was measured at 490 nm and 690 nm
using an ELISA reader. For each cell line a standard curve was
generated to compare invasiveness of different cell lines. Absor-
bance was plotted against certain numbers of cells and linear
regression analysis was performed. Linearity between the absor-
bance and the number of cells was seen within the range of 100
to 5610
4 cells per well. All assays were done in triplicate.
NO donor and NOS II inhibitor
Deta NONOate (NO donor) and 1400 W.2HCL (NOS II inhibitor)
were from Alexis (Gru ¨nberg, Germany). Deta NONOate was added
every 24 h and 1400 W only once at the beginning of an assay.
Both chemicals showed no effects on proliferation and viability
in the used concentrations as seen in direct cell counting using a
CASY cell counter (Scha ¨rfe Systems, Reutlingen, Germany).
Statistics
All data shown are from at least three independent experiments
and are expressed as mean+s.d. Statistical signiﬁcance was deter-
mined by using Student’s t-test. P-values smaller than 0.05 were
considered to be signiﬁcant.
RESULTS
NOS isoform expression in colorectal adenocarcinoma cell
lines HRT-18 and HT-29
The human colorectal adenocarcinoma cell lines HRT-18 and HT-
29 were used to investigate the role of NO in tumour cell invasion.
The cell lines differ in the expression of the NOS II isoform. As
shown by RT–MPCR both cell lines constitutively express NOS I
and NOS III mRNA, but HRT-18 cells constitutively express
NOS II mRNA, too (Figure 1).
Under non-stimulatory conditions HRT-18 cells generate more
NO, measured as nitrite, than HT-29 cells which can be explained
by the difference in NOS II expression (Table 2).
Induction of NOS II mRNA in HT-29 cells with a
combination of IFN-g and IL-1a
In HT-29 induction of NOS II mRNA was achieved after incuba-
tion with a combination of IFN-g and IL-1a in a concentration
dependent manner as shown by RT–PCR (Figure 2). A strong
cytotoxic effect was observed with 300 U ml
71 IFN-g and
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Table 1 Primers used
Ampliﬁcation
Primers product
GAPDH 5'-ACCACAGTCCATGCCATCAC-3' 452 bp
5'-TCCACCACCCTGTTGCTGTA-3'
NOS II 5'-GCAGAATGTGACCATCATGG-3' 426 bp
5'-ACAACCTTGGGGTTGAAGGC-3'
GAPDH
TNF-a
IL-1b
NOS III
NOS I
NOS II
Positive control
HT-29
HRT-18
H 2 O
100 bp ladder
Figure 1 Multiplex RT–PCR analysis of NOS isoform expression. The
presence of NOS I and NOS III mRNA was shown in both human color-
ectal adenocarcinoma cell lines HT-29 and HRT-18, NOS II mRNA was
only expressed in HRT-18.
NO promotes tumour cell invasiveness
A Siegert et al
1311
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(8), 1310–131510 ng ml
71 TNF-a, which correlates with a strong NOS II mRNA
expression.
Induction of NOS II mRNA in HT-29 cells after co-culture
with human monocytes
To investigate whether monocytes are able to induce NO produc-
tion in NOS II-negative HT-29 tumour cells, co-cultures were
performed in a transwell system, which allows separate RNA analy-
sis of the different cells. After 4, 8, 24 and 48 h of co-culture, RT–
PCR showed a strong induction of NOS II mRNA in HT-29 cells,
whereas the weak NOS II expression in monocytes remained
unchanged (Figure 3). In parallel cultures, total nitrite release
was increased at each time point in co-cultures compared to
monocytes and tumour cells alone (Table 3).
Invasiveness of HRT-18 and HT-29 cells
Invasiveness was assessed by a Boyden chamber coated with Matri-
gel
1. Both cell lines were invasive, but the level of invasion in the
HRT-18 cell line was three times higher than in the HT-29 cell line
(Figure 4). Because a parallelism was seen between the degree of
invasiveness and the amount of NO production we further investi-
gated whether a more causative relationship exist.
Inhibition of NO synthesis and invasion of HRT-18 cells by
1400 W
1400 W is an irreversible inhibitor of all NOS isoforms, but has a
much higher afﬁnity to NOS II compared to NOS I and NOS III.
Potency and selectivity of 1400 W to NOS II is greater than of any
other described NOS II inhibitors (Garvey et al, 1997). 1400 W
(0.5 mM) inhibited NO synthesis in HRT-18 cell line to approxi-
mately 40%, but had no effects on viability or proliferation.
Cytotoxic effects were seen with 10 mM 1400 W (data not shown).
Inhibition of NO synthesis by 1400 W was accompanied by a
signiﬁcant reduction of the Matrigel
1 invasion of the HRT-18 cell
line of about 50% (Figure 5).
Stimulation of invasion of HT-29 cells by Deta-NONOate
Deta NONOate is a NO donor with a half life of 20 h (Keefer et al,
1996). Two moles NO were released per mole of Deta NONOate.
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
s
Table 2 Nitrite in supernatants of HRT-18 and HT-29 cells
HT-29 HRT-18
NO2 per 10
6 cells per 4 days 0.15 mM 0.22 mM
NOS II
GAPDH
426 bp —
452 bp —
HT-29
control
300+10
100+1
50+1
10+1
100 bp ladder
IFN-g + IL-1a
H 2 O
Figure 2 Induction of NOS II mRNA expression in HT-29 cells by cyto-
kines. Cells were treated for 72 h with different concentrations of a com-
bination of human rIFN-g (300–10 U ml
71) and human rIL-1a (10–
1n gm l
71). RT–PCR showed a cytokine concentration-depending induc-
tion of NOS II mRNA.
NOS II
GAPDH
426 bp —
452 bp —
1      2        3        4 1      2        3        4 1      2        3        4 1       2        3          4 100 bp ladder
4 h 8 h 24 h 48 h
Figure 3 NOS II mRNA expression in HT-29/ monocyte co-cultures. RT–PCR of HT-29 cells (lane 1) and monocytes (lane 2) from transwell co-cultures
and in parallel of HT-29 (lane 3) and monocytes (lane 4) from monocultures at different time points is shown. Induction of NOS II mRNA was detected in
HT-29 cells at each time point of co-culture. GAPDH was used as an internal control.
Table 3 Nitrite in supernatants of monocytes, HT-29 and co-cultures
4h 8h 2 4h 4 8h
(mM)( mM)( mM)( mM)
Monocytes alone 38 39 39 32
HT-29 alone 51 51 51 51
Monocytes+HT-29 co-culture 49 57 62 63
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every 24 h to NOS II negative HT-29 cells increased the number
of invasive cells about 40% (Figure 6). This concentration had
no effects on viability. Cytotoxic effects were seen with 100 mM
(data not shown).
Stimulation of invasion of HT-29 cells by a combination of
IFN-g and IL-1a
Induction of NOS II in HT-29 cells by the cytokines IFN-g
(100 U ml
71) and IL-1a (1 ng ml
71) and production of NO by
the tumour cells itself signiﬁcantly increased Matrigel
1 invasion
of HT-29 cells about 75%. This effect was marginally abolished
by the NOS II inhibitor 1400 W (Figure 7), which proves a contri-
bution of NOS II in the process of tumour cell invasion. It also
indicates, that cytokines induce NO independent mechanisms of
tumour cell invasion.
DISCUSSION
For some human cancers elevated NOS activity has been reported.
The level of NOS protein and/or NOS activity has been positively
correlated with the degree of malignancy in human gynaecological
cancers (Thomsen et al, 1994), central nervous system tumours
(Cobbs et al, 1995), breast cancer (Thomsen et al, 1995), squa-
mous-cell carcinomas of the head and neck (Gallo et al, 1998),
lung cancer (Fujimoto et al, 1997) and oesophageal squamous cell
carcinoma (Tanaka et al, 1999). Obviously, NO plays an ambiva-
lent role in tumorigenesis depending on NOS activity and
resulting NO concentrations. Although there are some reports
showing induction of tumour cell apoptosis and cytostasis by high
levels of NO (Xie and Fidler, 1998), an increasing number of
reports shows a positive correlation between NO and tumour
progression (Thomsen and Miles, 1998) explained by NO-stimu-
lated migratory, invasive and angiogenic abilities of tumour cells
(Thomsen and Miles, 1998; Lala and Chakraborty, 2001).
This study clearly demonstrates, that NO increases the invasion
of the human colorectal adenocarcinoma cell lines HRT-18 and
HT-29. HRT-18 cells and HT-29 cells differ in NOS expression
and have different invasive capacities. The NOS II negative HT-
29 cells are less invasive indicating a role of NOS II in Matrigel
1
invasion. The invasiveness of HT-29 cells was further enhanced by
the exogen addition of NO or the induction of endogen NO
production by cytokines. In general, NOS II is inducible in a lot
of human tumour cell lines by pro-inﬂammatory cytokines (Thom-
sen and Miles, 1998). It has been shown too, that bacterial
infection of human colon epithelial cells is a sufﬁcient stimulus
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Figure 4 Matrigel
1 invasion by the human colorectal adenocarcinoma
cell lines HRT-18 and HT-29. HRT-18 cells are more invasive than HT-
29 cells. Cells were cultured on transwell cell culture inserts coated with
Matrigel
1. After 72 h cells were treated with MTT, and optical density
was measured after disolving the cells with DMSO. Optical density data
of invasive cells were converted into cell numbers on the basis of a stan-
dard curve for each cell line. Data of one out of three experiments are ex-
pressed as mean and standard deviation. *Signiﬁcant (P50.05) compared
to HRT-18 cells.
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Figure 5 Inhibition of HRT-18 Matrigel
1 invasion by 1400 W. HRT-18
cells were cultured on transwell cell culture inserts coated with Matrigel
1
and treated with the NOS II inhibitor 1400 W (0.5 mM) for 72 h. Data of
invasive cells, mean+s.d. of three independent experiments are shown.
*Signiﬁcant (P50.05) compared to HRT-18 untreated cells.
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Figure 6 Enhancement of HT-29 Matrigel
1 invasion by Deta NONO-
ate. HT-29 cells were cultured on transwell cell culture inserts coated with
Matrigel
1 and treated with the NO donor Deta NONOate (50 nM) for
72 h. Data of invasive cells, mean+s.d. of three independent experiments
are shown.
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Figure 7 Enhancement of HT-29 Matrigel
1 invasion by cytokines. HT-
29 cells were cultured on transwell cell culture inserts coated with Matri-
gel
1 and treated with human rIFN-g (100 U ml
71) and human rIL71a
(1 ng ml
71) for 72 h. This enhancement was slightly abrogated by addition
of the NOS II inhibitor 1400 W (0.5 mM). Data of invasive cells, mean+s.d.
of three independent experiments are shown. *Signiﬁcant (P50.05) com-
pared to HT-29 untreated cells.
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(Witthoft et al, 1998). Enhanced expression of NOS II and NOS
III has been recently discussed to correlate with tumour growth
and vascular invasion in human colorectal cancer (Yagihashi et
al, 2000; Lagares-Garcia et al, 2001). In our study the involvement
of the NOS II isoform in Matrigel
1 invasion of the colorectal
adenocarcinoma cell lines was evidenced by the inhibition of inva-
sion by 1400 W, the most selective NOS II inhibitor reported to
date. 1400 W never completely abolished the basal invasion of
HRT-18 or the cytokine-stimulated invasion of HT-29, which indi-
cates the existence of other invasion-inducing mechanisms beside
the NOS II/NO pathway.
Not investigated in this study were mediators of the NO-stimu-
lated invasion, which lead to essential steps as migration and
matrix degradation. Reduced migratory and invasive capacities of
the murine mammary cell lines C3L5 and C10 were demonstrated
with the NOS inhibitor L-NAME (Jadeski et al, 2000). Further-
more, NO promotes tumour cell invasion in the C3L5 murine
mammary adenocarcinoma model by altering the balance between
the expression of matrix metalloproteinase-2 (MMP-2) and it’s
tissue inhibitors-2 and -3 (TIMP 2 and TIMP 3) (Orucevic et al,
1999). Activation of MMP’s by NO has also been shown in chon-
drocytes (Murrell et al, 1995). Together, MMP’s and TIMP’s
modulate the structure of the extracellular matrix (ECM) and
changes of their expression level or activation of MMP’s weaken
the integrity of the ECM, which is a prerequisite for invasion
and metastasis (Kohn and Liotta, 1995).
Tumour-associated macrophages are the source of various cyto-
kines within malignant tumours, which can induce NOS II mRNA
expression. There is an earlier report describing the induction of
NOS II mRNA in co-cultures of the human urothelial bladder
carcinoma cell line RT4 and human monocytes (Konur et al,
1996). In co-cultures of the human colorectal adenocarcinoma cell
line HT-29 with human monocytes we found a similar strong
induction of NOS II mRNA in the HT-29 cell line, but no change
in the basal NOS II mRNA level in the monocytes. Therefore, the
enhanced nitrite concentration in the co-culture supernatants
probably result from NO synthesis in HT-29 cells, which has no
obvious cytotoxic effect until 48 h of co-culture. It is known from
rodents, that NO-derived reactive nitrogen intermediates (RNI)
produced by macrophages are cytotoxic against tumour cells
(Bogdan and Nathan, 1993). But the reported NOS activity in
human tumour cell lines or tumour tissues is at least 1–2 orders
of magnitude lower than the enzyme activity associated with the
cytotoxicity of rodent macrophages (Keller et al, 1990). The
production of RNI by monocytes in the used co-culture model
can not be proposed, since no relevant levels of RNI are produced
before maturation of monocytes to macrophages (Martin and
Edwards, 1993).
Tumour-associated macrophages are promoters of tumour
growth and invasion by different ways. This study shows that
pro-inﬂammatory cytokines induce NOS II expression and NO
synthesis in tumour cells. NO promotes tumour progression by
mechanisms like stimulation of angiogenesis (Jadeski and Lala,
1999), and as demonstrated in this study also by stimulation of
invasiveness.
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